Skip to content

Evaluation of Combination therapy of Glutathione with Ondansetron and Dexamethasone in the prevention of Post Operative Nausea and Vomiting in High Risk patients undergoing surgery under General Anaesthesia.

Evaluation of combination therapy of Glutathione with Ondansetron and Dexamethasone in the prevention of post operative nausea vomiting in high risk patients undergoing surgery under general anaesthesia - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086923
Enrollment
118
Registered
2025-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Combination Therapy of Glutathione with Ondansetron and Dexamethasone: The female non smoker patients age (18-55 years) scheduled for surgery under general anaesthesia with American Soc

Sponsors

Banaras Hindu University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: High risk females with Apfel s score

Exclusion criteria

Exclusion criteria: 1) Patient undergoing surgery under Total Intravenous Anaesthesia . 2) Patient with any systemic disease (mainly Liver disease, obstructive gastrointestinal pathology). 3) Patient allergic to Glutathione on any other drugs used in the study 4) Patient undergoing chemotherapy 5) Patient undergoing emergency surgery 6) Patient with any intramural pathology 7) Patient with history of nausea and vomiting

Design outcomes

Primary

MeasureTime frame
To study the incidence of PONV during the first 2 hours postsurgery in the high risk patients given combination therapy of Glutathione with Ondansetron and Dexamethasone intra operatively.Timepoint: To study the incidence of PONV during the first 2 hours postsurgery in the high risk patients given combination therapy of Glutathione with Ondansetron and Dexamethasone intra operatively.

Secondary

MeasureTime frame
1) To assess the incidence of PONV in the post anaesthetic care unit during 3 intervals ( 0-2 hours, 2-12 hours, 12-24 hours) 2) To assess severity of nausea using a 4 point scale (0= absent; 1 = mild, 2 = moderate, 3 = severe ) 3) To assess the number of patient administered rescue antiemetic (Metoclopramide 10mg) in the patient complaining of severe nausea or vomittingTimepoint: 0-2 hours 2-12 hours 12-24 hours

Countries

India

Contacts

Public ContactDr Reena

Institute of Medical Sciences, BHU

reena216@gmail.com9628679954

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026